1. FDA Guidance for Industry Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency. 2021, Food and Drug Administration:,Silver Spring, MD.
2. FDA Draft Guidance for Industry Conducting Remote Regulatory Assessments Questions and Answers. 2022, Food and Drug Administration, Silver Spring, MD.
3. FDA Warning Letter Dr Retter Ec Wladyslaw Retter. 2022, Food and Drug Administration, Silver Spring, MD.
4. FDA Warning Letter Nantong Furuida Packaging Products Co., Ltd. 2023, Food and Drug Administration, Silver Spring, MD.
5. FDA Warning Letter Ningbo Poplar Daily-Use. 2024, Food and Drug Administration, Sliver Spring, MD.